16 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private
10 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent
09 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private
02 Feb 2021 by admin in UncategorizedComments Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine
